Fig. 3From: Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potentialSplicing components as therapeutic targets. A number of techniques have been developed to chemically regulate splicing, in order to avoid the harmful effect of its dysregulation. Those techniques include chemical inhibitors of the core (top panel), regulators of splicing factors, like kinases inhibitors (middle panel), and oligonucleotides that bind to regulator sequences (bottom panel)Back to article page